243 related articles for article (PubMed ID: 9563903)
41. Antiproliferative function of p27kip1 is frequently inhibited in highly malignant Burkitt's lymphoma cells.
Barnouin K; Fredersdorf S; Eddaoudi A; Mittnacht S; Pan LX; Du MQ; Lu X
Oncogene; 1999 Nov; 18(46):6388-97. PubMed ID: 10597239
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of Hsp90 function by ansamycins causes retinoblastoma gene product-dependent G1 arrest.
Srethapakdi M; Liu F; Tavorath R; Rosen N
Cancer Res; 2000 Jul; 60(14):3940-6. PubMed ID: 10919672
[TBL] [Abstract][Full Text] [Related]
43. Enhanced protein stability: a novel mechanism of D-type cyclin over-abundance identified in human sarcoma cells.
Welcker M; Lukas J; Strauss M; Bartek J
Oncogene; 1996 Jul; 13(2):419-25. PubMed ID: 8710382
[TBL] [Abstract][Full Text] [Related]
44. Several noncontiguous domains of CDK4 are involved in binding to the P16 tumor suppressor protein.
Ceha HM; Nasser I; Medema RH; Slebos RJ
Biochem Biophys Res Commun; 1998 Aug; 249(2):550-5. PubMed ID: 9712735
[TBL] [Abstract][Full Text] [Related]
45. Aberrant expression of the Rb pathway proteins in soft tissue sarcomas.
Sabah M; Cummins R; Leader M; Kay E
Appl Immunohistochem Mol Morphol; 2006 Dec; 14(4):397-403. PubMed ID: 17122635
[TBL] [Abstract][Full Text] [Related]
46. Lack of p16INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines.
He J; Olson JJ; James CD
Cancer Res; 1995 Nov; 55(21):4833-6. PubMed ID: 7585516
[TBL] [Abstract][Full Text] [Related]
47. Frequent overexpression of cyclin D2/cyclin-dependent kinase 4 in Wilms' tumor.
Faussillon M; Monnier L; Junien C; Jeanpierre C
Cancer Lett; 2005 Apr; 221(1):67-75. PubMed ID: 15797629
[TBL] [Abstract][Full Text] [Related]
48. RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancer.
Kaye FJ
Oncogene; 2002 Oct; 21(45):6908-14. PubMed ID: 12362273
[TBL] [Abstract][Full Text] [Related]
49. Immunohistochemical detection of CDK4 and p16INK4 proteins in cutaneous malignant melanoma.
Wang YL; Uhara H; Yamazaki Y; Nikaido T; Saida T
Br J Dermatol; 1996 Feb; 134(2):269-75. PubMed ID: 8746340
[TBL] [Abstract][Full Text] [Related]
50. The p16(INK4A) protein and flavopiridol restore yeast cell growth inhibited by Cdk4.
Moorthamer M; Panchal M; Greenhalf W; Chaudhuri B
Biochem Biophys Res Commun; 1998 Sep; 250(3):791-7. PubMed ID: 9784425
[TBL] [Abstract][Full Text] [Related]
51. Novel mutations in the p16/CDKN2A binding region of the cyclin-dependent kinase-4 gene.
Tsao H; Benoit E; Sober AJ; Thiele C; Haluska FG
Cancer Res; 1998 Jan; 58(1):109-13. PubMed ID: 9426066
[TBL] [Abstract][Full Text] [Related]
52. [Methylation and expression analysis of p16(INK4a) and RB genes in meningiomas].
Chen MN; Mao Q; Liu YH; Mao BY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Jun; 21(3):277-9. PubMed ID: 15192837
[TBL] [Abstract][Full Text] [Related]
53. Inverse expression of Cdk4 and p16 in epithelial ovarian tumors.
Sui L; Dong Y; Ohno M; Goto M; Inohara T; Sugimoto K; Tai Y; Hando T; Tokuda M
Gynecol Oncol; 2000 Nov; 79(2):230-7. PubMed ID: 11063650
[TBL] [Abstract][Full Text] [Related]
54. Loss of p16(INK4a) is associated with reduced patient survival in soft tissue tumours, and indicates a senescence barrier.
Knösel T; Altendorf-Hofmann A; Lindner L; Issels R; Hermeking H; Schuebbe G; Gibis S; Siemens H; Kampmann E; Kirchner T
J Clin Pathol; 2014 Jul; 67(7):592-8. PubMed ID: 24747207
[TBL] [Abstract][Full Text] [Related]
55. Cooperative alterations of Rb pathway regulators in mouse primary T cell lymphomas.
Pérez de Castro IP; Malumbres M; Santos J; Pellicer A; Fernández-Piqueras J
Carcinogenesis; 1999 Sep; 20(9):1675-82. PubMed ID: 10469610
[TBL] [Abstract][Full Text] [Related]
56. Genes involved in melanoma: an overview of INK4a and other loci.
Castellano M; Parmiani G
Melanoma Res; 1999 Oct; 9(5):421-32. PubMed ID: 10596908
[TBL] [Abstract][Full Text] [Related]
57. Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas.
Khatib ZA; Matsushime H; Valentine M; Shapiro DN; Sherr CJ; Look AT
Cancer Res; 1993 Nov; 53(22):5535-41. PubMed ID: 8221695
[TBL] [Abstract][Full Text] [Related]
58. Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene.
Ichimura K; Schmidt EE; Goike HM; Collins VP
Oncogene; 1996 Sep; 13(5):1065-72. PubMed ID: 8806696
[TBL] [Abstract][Full Text] [Related]
59. Astrocyte-specific expression of CDK4 is not sufficient for tumor formation, but cooperates with p53 heterozygosity to provide a growth advantage for astrocytes in vivo.
Huang ZY; Baldwin RL; Hedrick NM; Gutmann DH
Oncogene; 2002 Feb; 21(9):1325-34. PubMed ID: 11857076
[TBL] [Abstract][Full Text] [Related]
60. Epidermal growth factor and transforming growth factor-alpha-associated overexpression of cyclin D1, Cdk4, and c-Myc during hepatocarcinogenesis in Helicobacter hepaticus-infected A/JCr mice.
Ramljak D; Jones AB; Diwan BA; Perantoni AO; Hochadel JF; Anderson LM
Cancer Res; 1998 Aug; 58(16):3590-7. PubMed ID: 9721866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
